Home/Filings/4/0001493152-23-021430
4//SEC Filing

Dexter Susan 4

Accession 0001493152-23-021430

CIK 0001106838other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:15 PM ET

Size

5.4 KB

Accession

0001493152-23-021430

Insider Transaction Report

Form 4
Period: 2023-06-14
Dexter Susan
Chief Technical Officer
Transactions
  • Purchase

    Common Stock

    2023-06-14$0.70/sh+10,000$7,00033,667 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6972 to $0.6999 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  • [F2]Includes unvested restricted stock awards.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001806764

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:15 PM ET
Size
5.4 KB